|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operations: | |||||
| Depreciation, depletion and amortization | |||||
| Amortization of operating lease ROU | |||||
| Amortization of debt discount | |||||
| Loss on extinguishment of debt | |||||
| Success fee paid on Share Exchange by controlling shareholder | |||||
| Shares issued as commitment fee for equity line of credit | |||||
| Impairment of technology licenses | |||||
| Impairment expense | |||||
| Impairment of equity investment – Hupecol Meta LLC | |||||
| Loss on disposal of oil and gas properties – Colombia | |||||
| Accretion of plugging and abandonment costs | |||||
| Write off of application costs on abandoned patent applications | |||||
| Provision for loss on convertible note receivable | |||||
| Changes in operating assets and liabilities: | |||||
| Increase in accounts receivable | |||||
| Decrease (increase) in government grant receivable | |||||
| Increase in prepaid expenses | |||||
| Decrease (increase) in other current assets | |||||
| Increase in accrued interest receivable | |||||
| (Increase)/Decrease in prepaid expense and other current assets | |||||
| Increase in other assets | |||||
| Increase (decrease) in accounts payable and accrued expenses | |||||
| Decrease in operating lease liability | |||||
| Increase in accrued interest payable | |||||
| Increase (decrease) in other payables | |||||
| Net cash used in operating activities | |||||
| CASH FLOWS FROM INVESTING ACTIVITIES | |||||
| Payments for capital contribution for equity investment | |||||
| Payment related to patent application costs | |||||
| Purchase of fixed assets | |||||
| Payments for technology license | |||||
| Cash acquired in Share Exchange | |||||
| Net cash used in investing activities | |||||
| CASH FLOWS FROM FINANCING ACTIVITIES | |||||
| Proceeds from issuance of common stock for cash, net of offering costs | |||||
| Capital contributions | |||||
| Proceeds from issuance of HUSA convertible note | |||||
| Repayment of HUSA convertible note including prepayment penalties | |||||
| Proceeds from equity line of credit draw downs | |||||
| Net proceeds on share issuances | |||||
| Advances under notes payable – related party | |||||
| Repayments on notes payable – related party | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes | |||||
| Net Change in Cash and Cash Equivalents | |||||
| Cash, beginning of period | |||||
| Cash, end of period | |||||
| Interest paid | |||||
| SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES | |||||
| Change in estimate of asset retirement obligations, net | |||||
| Net assets assumed in Share Exchange, excluding cash | |||||
| Shares issued as commitment fee for equity line of credit | |||||
| Success fee paid on Share Exchange by controlling shareholder | |||||
| Operating lease right of use asset | |||||
| Purchase of fixed assets funded by accounts payable | |||||
Loading...